Form D · Biotechnology
Vicora, Inc.
Buffalo, NY · CIK 0002091847
Offering snapshot reported Sep 18, 2026 · SEC filing
- Reported sold
- $2.3M Offering amount: $2.5M
- Investors reported
- 59 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Apr 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2026 | Initial | $2,300,000 | No comparison | 59 | SEC filing |
| Oct 20, 2025 | Initial | $3,400,000 | No comparison | 55 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598092
Source: Form D, filed Sep 18, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Colpoys | Director, Executive |
| Richard Ducharme | Director, Executive |
| William Maggio | Director |
| Shawn Patterson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
665 Northland Avenue
Buffalo, NY, 14211
Phone: 7165362971
Buffalo, NY, 14211
Phone: 7165362971